Related Experiment Video
Updated: Jun 10, 2026
08:47
Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver Cells
Published on: March 30, 2016
Human foetal hepatocytes: isolation, characterization, and transplantation
Anne Weber1, Thomas Touboul, Sylvie Mainot
1INSERM U972, Université Paris-Sud, Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
Methods in Molecular Biology (Clifton, N.J.)
|July 21, 2010
Summary
Human fetal liver cells offer a promising alternative source for hepatocytes, showing successful engraftment and differentiation after transplantation. This research supports cell therapy strategies for liver metabolic diseases.
Area of Science:
- Regenerative Medicine
- Hepatology
- Stem Cell Biology
Background:
- Hepatocyte transplantation is an alternative to liver transplantation for metabolic diseases.
- Donor organ shortage and limitations of mature hepatocytes necessitate alternative cell sources.
- Hepatic progenitors and fetal hepatocytes are potential sources for generating functional hepatocytes.
Purpose of the Study:
- To evaluate the therapeutic potential of human fetal liver cells for liver cell therapy.
- To investigate the engraftment and differentiation capacity of these cells post-transplantation.
- To explore the feasibility of using fetal cell populations for gene therapy.
Main Methods:
- Isolation and in vitro culture of human fetal liver cells.
- Transplantation of cultured cells into immunodeficient mice.
- Assessment of cell engraftment and differentiation into mature hepatocytes in situ.
- Evaluation of gene transfer efficiency using retroviral vectors.
Main Results:
- Human fetal liver cells can be successfully isolated and cultured.
- Transplanted cells engraft and differentiate into mature hepatocytes within the host liver.
- Efficient gene transfer is achievable in these fetal cell populations.
Conclusions:
- Human fetal liver cells represent a viable alternative source for hepatocyte generation.
- These cells hold significant potential for liver cell therapy and gene therapy applications.
- Further development of these approaches could lead to clinical strategies for liver metabolic diseases.
